1f
12
9
1a
8
20
8
49
16
8
19
1
49
2
8
1b
1d
18
79
35
1d
2 29
1d
25
35
Madhura A. Tamhankar, MD
71Professor of Ophthalmology at the Hospital of the University of Pennsylvania
28
7a
3
64
Attending Surgeon, Scheie Eye Institute, University of Pennsylvania
11
Department: Ophthalmology
4
1
b
1d
46
Contact information
42
4
3
3
1d
42
Scheie Eye Institute
23 Department of Ophthalmology
3d University of Pennsylvania
Philadelphia, PA 19104
26
23 Department of Ophthalmology
3d University of Pennsylvania
Philadelphia, PA 19104
35
f
18
Publications
23 a
3
2
29
23 a
Links
fb Search PubMed for articles
ab MEdEd Talks POdcast- Thyroid Eye Disease Screening and Diagosis by Drs Prem Subramanian and Dr Madhura Tamhankar
66 Preparing Patients for TED Treatment
75 A short video
91 Video of case description highlighting differential Diagnosis of TED
73 Preview of Neuro-ophthalmology Subday
c
4
b
1f
fb Search PubMed for articles
ab MEdEd Talks POdcast- Thyroid Eye Disease Screening and Diagosis by Drs Prem Subramanian and Dr Madhura Tamhankar
66 Preparing Patients for TED Treatment
75 A short video
91 Video of case description highlighting differential Diagnosis of TED
73 Preview of Neuro-ophthalmology Subday
c
13
Education:
21 9 M.D. c
3b University Hospital, Bombay, India, 1993.
c
3
3
21
21 9 M.D. c
3b University Hospital, Bombay, India, 1993.
c
1f
Post-Graduate Training
24 55 Intern in Medicine, University Hospital, Bombay, Indian, 1993-1994.
24 5c Residency in Ophthalmology, University Hospital, Bombay, India, 1994-1997.
24 51 Research Fellowship in Glaucoma, Wills Eye Hospital, 1998-2000.
24 65 Internship in Preliminary Surgery, Yale University, St. Mary's Hospital, 2000-2001.
24 71 Fellowship in Neuro-ophthalmology, Scheie Eye Institute, University of Pennsylvania, 2002-2003.
24 6a Residency in Ophthalmology, Scheie Eye Institute, University of Pennsylvania, 2004-2007.
c
3
25
24 55 Intern in Medicine, University Hospital, Bombay, Indian, 1993-1994.
24 5c Residency in Ophthalmology, University Hospital, Bombay, India, 1994-1997.
24 51 Research Fellowship in Glaucoma, Wills Eye Hospital, 1998-2000.
24 65 Internship in Preliminary Surgery, Yale University, St. Mary's Hospital, 2000-2001.
24 71 Fellowship in Neuro-ophthalmology, Scheie Eye Institute, University of Pennsylvania, 2002-2003.
24 6a Residency in Ophthalmology, Scheie Eye Institute, University of Pennsylvania, 2004-2007.
c
17
Certifications
28 43 North American Neuro-Ophthalmology Society, 2003.
28 38 American Board of Ophthalmology, 2009.
c
3
8b
Permanent link28 43 North American Neuro-Ophthalmology Society, 2003.
28 38 American Board of Ophthalmology, 2009.
c
2 29
21
1e
1d
24
5e
8
18d Dr.Tamhankar has research interests in thyroid eye disease and giant cell arteritis. She is the principal investigator on several clinical trials exploring new therapies for thyroid eye disease. She collaborates with an International Vasculitis Clinical Research Consortium to study MR imaging in giant cell arteritis and helped develop a standardized imaging protocol and scoring system.
8
157 She is actively involved in teaching learners at all levels—including neuro-ophthalmology fellows, residents, medical students, and undergraduates both in the clinic and through engagement in research activities. Her teaching emphasizes critical thinking and the application of scientific evidence to complex clinical decision-making.
65
8
1c5 Key Words: Optic nerve diseases, Double vision, Strabismus Surgery, Blepharospasm and hemifacial spasm, Giant Cell Arteritis, Optic Neuritis, Orbital Inflammation, Multiple sclerosis, Myasthenia gravis, Pupillary abnormalities, Thyroid eye disease, Brain tumors that affect vision, eye movement abnormalities, Idiopathic intracranial hypertension (AKA pseudotumor cerebri, Stroke affecting vision, Traumatic brain injuries) and strabismus.
1a 29
27
Description of Research Expertise
326 Dr.Tamhankar is a Professor of Ophthalmology at the Scheie Eye Institute, University of Pennsylvania. She is fellowship trained in Neuro-ophthalmology and serves as the primary point of contact for referrals from various specialties including neurosurgery, neurology, endocrinology, rheumatology, and general medicine. She is also the only adult strabismus surgeon at the institute, with a large referral network for strabismus surgery, attracting patients from Philadelphia and its surrounding suburbs. Additionally, she co-leads the thyroid eye disease clinic in collaboration with the oculoplastic service. This clinic is a key referral center for patients seeking medical and surgical treatments for complex thyroid eye disease and those considering participation in clinical trials.8
18d Dr.Tamhankar has research interests in thyroid eye disease and giant cell arteritis. She is the principal investigator on several clinical trials exploring new therapies for thyroid eye disease. She collaborates with an International Vasculitis Clinical Research Consortium to study MR imaging in giant cell arteritis and helped develop a standardized imaging protocol and scoring system.
8
157 She is actively involved in teaching learners at all levels—including neuro-ophthalmology fellows, residents, medical students, and undergraduates both in the clinic and through engagement in research activities. Her teaching emphasizes critical thinking and the application of scientific evidence to complex clinical decision-making.
65
Description of Clinical Expertise
6c Areas of Expertise: Neuro-ophthalmology, strabismus, orbital disorder, thyroid eye disease8
1c5 Key Words: Optic nerve diseases, Double vision, Strabismus Surgery, Blepharospasm and hemifacial spasm, Giant Cell Arteritis, Optic Neuritis, Orbital Inflammation, Multiple sclerosis, Myasthenia gravis, Pupillary abnormalities, Thyroid eye disease, Brain tumors that affect vision, eye movement abnormalities, Idiopathic intracranial hypertension (AKA pseudotumor cerebri, Stroke affecting vision, Traumatic brain injuries) and strabismus.
1a 29
23
153 Levin LA, Bhatti MT, Klier S, Morgenstern R, Szanto D, Miller NR, Kupersmith MJ; Quark NAION Study Group.: A Randomized Sham-Controlled Phase 2/3 Trial of QPI-1007 for Acute Nonarteritic Anterior Ischemic Optic Neuropathy. Ophthalmology 133(1): 62-74, January 2026.
1c2 Shah SA, Chandraparnik P, Choi S, Amarikwa L, Guniganti R, Walsh HL, Rubio RH, Linaburg T, Meyer E, Reem K, Sears C, Goldin M, Kinde B, Dosiou C, Malik A, Mawn L, Shinder R, Wester S, Rootman D, Cockerham K, Tamhankar M, Couch S, Harrison A, Kossler AL. : The Efficacy and Safety of Teprotumumab in Geriatrics Patients: A Multicenter Study. OPRS 42(1): 102-109, January 2026.
193 Yuanyuan Chen, Taylor Linaburg, Sarah Wang, Gibran Merchant, Tejus Pradeep, Patrick Anthony Augello, Gui-shuang Ying, César A. Briceño, Madhura A. Tamhankar: Observational Characterization of the Re-treatment Course of Patients with Thyroid Eye Disease. Journal of Neuro-ophthalmology January 2025 Notes: Online ahead of print.
122 Tamhankar MA, Raza S, Brutsaert E, Urdániz E, Vainilovich Y, Heyes A, Gildea L, Sales-Sanz M.: The burden of illness in thyroid eye disease: current state of the evidence. Front Ophthalmol(Lausanne). 5, April 2025.
11f Rennie L. Rhee, Girish Bathla, Ryan Rebello, Robert M. Kurtz, Mats Junek, Kenneth J. Warrington, Nader Khalidi, Peter A. Merkel1, Konstanze V. Guggenberger, Madhura A. Tamhankar, Thorsten A. Bley for the Vasculitis Clinical Research Consortium ca : Vessel wall MRI in giant cell arteritis: standardized protocol and scoring approach developed by an international working group. Rheumatology 64(5): 2910-2918, May 2025.
146 Linaburg TJ, Pradeep T, Rinelli B, Chen Y, Chen Y, Ying GS, Briceño CA, Tamhankar M: Comparison of ophthalmic surgery rates in teprotumumab-treated vs. teprotumumab-untreated thyroid eye disease patients. Arq Bras Oftalmol 88(5): 2024-0319, July 2025.
12f Kasi S, Volpe NJ, Pistilli M, Tamhankar MA: Effectiveness of Medial Rectus Advancement Alone or in Combination with Resection or Lateral Rectus Recession in the Management of Consecutive Exotropia. JAAPOS 17(5): 465-470, Oct 2013.
119 Madhura Tamhankar, Brady kwong Maxwell Pistilli: Benefits and side effects of prisms in the management of diplopia in adults: a prospective study. Journal of the American Association for Pediatric Ophthalmology and Strabismus. 34 25(2): 85.e1-85.e6, April 2021.
c7 Kruszewski AM, Tamhankar MA.: Ophthalmic Manifestations of Giant Cell Arteritis. Int Ophthalmol Clin 63(2): 13-23, April 2023.
2c
7
1d
1f
Selected Publications
154 Ahmed W, Gandhi OH, Yu N, Brant J, Hwa T, Bagley L, Tamhankar M, Feroze A, Choudhri O.: Efficacy of glucagon-like peptide-1 receptor agonists in idiopathic intracranial hypertension: A systematic review and meta-analysis. J. Neurol Sci. 480: 125711, January 2026.153 Levin LA, Bhatti MT, Klier S, Morgenstern R, Szanto D, Miller NR, Kupersmith MJ; Quark NAION Study Group.: A Randomized Sham-Controlled Phase 2/3 Trial of QPI-1007 for Acute Nonarteritic Anterior Ischemic Optic Neuropathy. Ophthalmology 133(1): 62-74, January 2026.
1c2 Shah SA, Chandraparnik P, Choi S, Amarikwa L, Guniganti R, Walsh HL, Rubio RH, Linaburg T, Meyer E, Reem K, Sears C, Goldin M, Kinde B, Dosiou C, Malik A, Mawn L, Shinder R, Wester S, Rootman D, Cockerham K, Tamhankar M, Couch S, Harrison A, Kossler AL. : The Efficacy and Safety of Teprotumumab in Geriatrics Patients: A Multicenter Study. OPRS 42(1): 102-109, January 2026.
193 Yuanyuan Chen, Taylor Linaburg, Sarah Wang, Gibran Merchant, Tejus Pradeep, Patrick Anthony Augello, Gui-shuang Ying, César A. Briceño, Madhura A. Tamhankar: Observational Characterization of the Re-treatment Course of Patients with Thyroid Eye Disease. Journal of Neuro-ophthalmology January 2025 Notes: Online ahead of print.
122 Tamhankar MA, Raza S, Brutsaert E, Urdániz E, Vainilovich Y, Heyes A, Gildea L, Sales-Sanz M.: The burden of illness in thyroid eye disease: current state of the evidence. Front Ophthalmol(Lausanne). 5, April 2025.
11f Rennie L. Rhee, Girish Bathla, Ryan Rebello, Robert M. Kurtz, Mats Junek, Kenneth J. Warrington, Nader Khalidi, Peter A. Merkel1, Konstanze V. Guggenberger, Madhura A. Tamhankar, Thorsten A. Bley for the Vasculitis Clinical Research Consortium ca : Vessel wall MRI in giant cell arteritis: standardized protocol and scoring approach developed by an international working group. Rheumatology 64(5): 2910-2918, May 2025.
146 Linaburg TJ, Pradeep T, Rinelli B, Chen Y, Chen Y, Ying GS, Briceño CA, Tamhankar M: Comparison of ophthalmic surgery rates in teprotumumab-treated vs. teprotumumab-untreated thyroid eye disease patients. Arq Bras Oftalmol 88(5): 2024-0319, July 2025.
12f Kasi S, Volpe NJ, Pistilli M, Tamhankar MA: Effectiveness of Medial Rectus Advancement Alone or in Combination with Resection or Lateral Rectus Recession in the Management of Consecutive Exotropia. JAAPOS 17(5): 465-470, Oct 2013.
119 Madhura Tamhankar, Brady kwong Maxwell Pistilli: Benefits and side effects of prisms in the management of diplopia in adults: a prospective study. Journal of the American Association for Pediatric Ophthalmology and Strabismus. 34 25(2): 85.e1-85.e6, April 2021.
c7 Kruszewski AM, Tamhankar MA.: Ophthalmic Manifestations of Giant Cell Arteritis. Int Ophthalmol Clin 63(2): 13-23, April 2023.
2c